Core Viewpoint - Medline Inc. is not selling any shares in the public offering, which involves 75,000,000 shares of its Class A common stock being offered by certain selling stockholders affiliated with major investment firms [1][2] Group 1: Offering Details - The selling stockholders intend to grant underwriters a 30-day option to purchase an additional 11,250,000 shares of Medline's Class A common stock [1] - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan are acting as global coordinators and joint bookrunning managers for the offering [2] - The offering will be made only by means of a prospectus, and copies of the preliminary prospectus can be obtained from the mentioned financial institutions [3] Group 2: Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, serving all points of care globally [5] - The company has a broad product portfolio, resilient supply chain, and leading clinical solutions aimed at improving healthcare providers' clinical, financial, and operational outcomes [5] - Medline is headquartered in Northfield, Illinois, employs over 45,000 people worldwide, and operates in more than 100 countries [5]
Medline Inc. announces launch of secondary offering of Class A common stock